In nervous tissue the reuptake process appears to be the main mechanism whereby the physiological activity of the neurotransmitters is terminated. There is evidence that the entry and efflux of biogenic amines such as noradrenaline, dopamine (3,4-dihydroxyphenethylamine) and 5-hydroxytryptamine (serotonin), which have been shown to have a transmitter function in the mammalian brain, is a Na++K+-dependent process that is ouabain-sensitive (Akera et al., Blaszkowski & Bogdanski, 1972) . This suggests that Na++K+-dependent ATPaset may have a regulatory function in synaptic transmission.
In nervous tissue the reuptake process appears to be the main mechanism whereby the physiological activity of the neurotransmitters is terminated. There is evidence that the entry and efflux of biogenic amines such as noradrenaline, dopamine (3,4-dihydroxyphenethylamine) and 5-hydroxytryptamine (serotonin), which have been shown to have a transmitter function in the mammalian brain, is a Na++K+-dependent process that is ouabain-sensitive (Akera et al., 1970; Blaszkowski & Bogdanski, 1972) . This suggests that Na++K+-dependent ATPaset may have a regulatory function in synaptic transmission.
It is well established that many clinically effective drugs that have been or are used in the treatment of mental diseases also affect brain amine metabolism, by stimulating release and decreasing amine reuptake (e.g. amphetamine; Carr & Moore, 1969) , by selectively decreasing amine reuptake (e.g. amitriptyline; see Schildkraut, 1970) , by blocking dopaminergic and adrenergic receptors (e.g. chlorpromazine; Bunney et al., 1973) or by increasing amine reuptake into the presynaptic neuron (e.g. LiCI; see Colburg et al., 1968) . There is increasing evidence that the effect of these drugs on brain amine metabolism is causally related to their clinical efficacy (see Mendels, 1973) . As centrally acting drugs such as morphine, trans-Ag-tetrahydrocannabinol and ethanol stimulate Na++K+-dependent ATPase in rat brain (Jain et al., 1974) , we decided to investigate what effects a central stimulant (amphetamine), an anti-depressant (amitriptyline), an anti-psychotic (chlorpromazine) and an anti-manic (LiCI) drug had on the activity of ATPases in ten regions of the rat brain. Our aim was to test whether it was possible to relate the differences in the pharmacological activities of these drugs to their effects on the ATPases in different functional regions of the brain.
Groups of four male rats (Wistar; body wt. 200-3OOg) were injected intraperitoneally with 0.9 % NaCl (controls), D-amphetamine (5mg/kg body wt.), amitriptyline (20mg/kg body wt.), chlorpromazine (lOmg/kg body wt.) or LiCl(SOmg/kg body wt.) and decapitated 1 h later. The brains were rapidlyremoved, placed on ice and dissected into the brain stem (pons+medulla), cerebellum, corpora quadrigemina (tegmentum+colliculus), thalamus+ hypothalamus, hippocampus, striatum, olfactory lobes, neocortex, septum and amygdaloid cortex. The brain regions were homogenized by sonication for 1.5min in a sucrose-EDTA-deoxychotate medium, pH 7.4, and centrifuged at 20000g for 30min. Portions of theclear supernatant wereadded to an incubation medium containing (final concentrations) 5m~-MgcI,, 1 ~~M -K C I , 90m~-NaC1 and ~~M -A T P ; oubain (1 mM) was added in some cases to inhibit Na++K+-dependent ATPase activity. Total ATPase activity was taken to be the activity occurring in theabsence of ouabain; Mgz+-dependent ATPase activity was assumed to be the activity remaining after ouabain inhibition. ATPase activity was determined by measuring the release of PI from ATP after a 5min incubation period at 37°C. The enzyme activity is expressed as pmol of PI liberated h per mg of protein.
The results are summarized in Table 1 . Amphetamine increases the total and Mgz+-dependent ATPase activities in the septum and amygdaloid cortex. The Na++K+-dependent ATPase activity was also increased in the septum and striatum. Dopamine has been implicated as the main transmitter substance in parts of the limbic system; it also plays a primary role in the function of the striatum. As amphetamine probably acts by releasing dopamine, as well as noradrenaline, in the brain (see Bunney et al., 1973) , it can tentatively be concluded that the effect of amphetamine on the activity of the ATPases could be related to its pharmacological activity.
$ Abbreviation : ATPase, adenosine triphosphatase. 
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Chlorpromazine has a totally different spectrum of activity from that of amphetamine. Thus it decreases total ATPase activity in the neocortex and hippocampus, Mg2+-dependent ATPase activity in the olfactory lobes, brain stem, cerebellum, corpora quadrigemina, striaturn and thalamus and Na++K+-dependent ATPase activity in the olfactory lobes and corpora quadrigemina. There is evidence that chlorpromazine blocks postsynaptic dopaminergic and noradrenergic receptor sites and thereby increases amine turnover by feedback inhibition. The decrease in ATPase activity is therefore unlikely to be a reflexion of this increased amine turnover.
Amitriptyline appears to affect ATPase activity primarily in the olfactory lobes. Total and Mgz+-dependent ATPase activities were increased in this area. The Na++K+-dependent ATPase activity was also decreased in the thalamus and hippocampus. Whether the relatively specific effects of this anti-depressant drug on ATPase activity in these three brain regions is related to its clinical efficacy must await further evidence.
LiCl decreases total, Mgz+-dependent and Nat + K+-dependent ATPase activities in most regions of the brain. It is generally accepted that the primary action of this drug is to inhibit Na++K+-dependent ATPase activity, an effect that may underlie the clinical action of the drug. The results of the present study also show that this drug inhibits both Na++K+-dependent and Mgzt-dependent ATPase activities in most regions of the brain.
It can be concluded that all four therapeutic classes of psychotropic drugs that we have studied have different effects on the ATPases in ten regions of the rat brain. However, it seems unlikely that the action of these drugs on ATPase activity can be causally related to their pharmacological activity.
